Simplex Trading, LLC Icosavax, Inc. Transaction History

Simplex Trading, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$5.95 - $15.79 $1,612 - $4,279	271 Added 67.08%	675 $10,000
Q3 2023 Nov 01, 2023	SELL	$7.22 - $10.05 $24,071 - $33,506	-3,334 Reduced 89.19%	404 $3,000
Q2 2023 Aug 04, 2023	BUY	$4.89 - $10.57 $11,603 - $25,082	2,373 Added 173.85%	3,738 $37,000
Q1 2023 Apr 27, 2023	SELL	$5.62 - $11.51 $8,992 - $18,416	-1,600 Reduced 53.96%	1,365 $7,000
Q4 2022 Feb 02, 2023	BUY	$2.32 - $10.97 $6,767 - $31,999	2,917 Added 6077.08%	2,965 $23,000
Q3 2022 Nov 04, 2022	SELL	$3.09 - $9.21 $5,966 - $17,784	-1,931 Reduced 97.57%	48 $0
Q2 2022 Aug 03, 2022	BUY	$5.7 - $10.33 $11,280 - $20,443	1,979 New	1,979 $11,000

1.37M

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.